+1-786-628-7980
Sign Up/Sign In 
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Genomic Cancer Panel and Profiling Market – (By Tissue Testing (Solid Tissue Testing, Liquid Tissue Testing), By Cancer Panel Type (Single-Gene Panel, Multi-Gene Panel), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, Prostate Cancer, Other Cancers), By Application (Clinical, Research), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Others), By End User (Hospitals, Clinical and Diagnostic Laboratories, Research and Academic Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”
Genomic cancer panels and profiling entail examining a patient’s cancer DNA to detect genetic mutations and alterations that potentially contribute to the onset and advancement of cancer. The wealth of genetic information aids early identification and the development of tailored treatment plans these panels may provide.
Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/2292
Genomic cancer profiling and panels are causing a stir in the market because of their revolutionary potential for cancer treatment. Genetic panels and profiling tests are in high demand due to the rising incidence of hereditary cancers worldwide. The primary reason for this is the remarkable effectiveness and accuracy of cancer gene panels and profiling services in identifying cases of hereditary cancer. However, poor storage conditions, an increase in immunotherapy, and a lack of access to testing samples are some of the barriers restricting the overall expansion of the industry.
List of Prominent Players in the Genomic Cancer Panel and Profiling Market:
Market Dynamics:
Drivers-
The growing demand for genomic cancer panels and profiling market is fueled by the fast advancements in oncology biomarker research and clinical molecular diagnostics. New therapeutic options and pharmacological targets have been developed. Biomarkers are crucial in clinical research when diagnosing diseases, creating individualized drug plans, and finding surrogate endpoints. In recent years, greater sensitivity and specificity in biomarkers have been the focus of increasing scientific and clinical research across various treatment disciplines. Due to their demonstrated usefulness in accurate cancer diagnoses, there will likely be an uptick in using biomarkers in the cancer/tumour profiling industry.
Order this Premium Report: https://www.insightaceanalytic.com/buy-report/2292
Challenges:
The prime challenge is high cost, a shortage of competent individuals and a lack of norms and protocol because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the genomic cancer panel and profiling market. Considerable financial costs are incurred in the search, production, and validation of biomarkers for use in cancer diagnosis and prognosis. The clinical field cannot use a newly generated candidate biomarker without proof. The rate of discovery of potential biomarkers outpaces the rate of validation. The high cost of these tests makes them out of reach for many patients, limiting their use in cancer profiling. The stringent regulations have impeded regular cancer tests due to the coronavirus outbreak, such as limiting contact and instituting lockdown precautions. The decreased number of false positives caused by COVID-19 infections has dramatically dropped cancer cases.
Regional Trends:
The North American genomic cancer panel and profiling market is anticipated to record a major market share in revenue. It is projected to grow at a high CAGR in the near future due to more investment in research and development and an increase in cancer cases associated with the genomic cancer panel and profiling. Besides, Europe had a considerable market share due to technological advancements and affluence. The demand for targeted oncology treatments, healthcare infrastructure improvements, the frequency of genomic cancer panels and profiling in different cancer types, and the pace of drug discovery and development are all potential drivers of market expansion in this field.
Recent Developments:
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/2292
Segmentation of Genomic Cancer Panel and Profiling Market-
By Tissue Testing-
By Cancer Panel Type
By Cancer Type-
By Application-
By Technology-
By End User-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Details insights on this market: https://www.insightaceanalytic.com/report/genomic-cancer-panel-and-profiling-market/2292
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
